[Study of the ototoxicity of amikacin and netilmicin using provoked acoustic oto-emissions and high-frequency audiometry].
To compare the ototoxicity of amikacin and netilmicin, tone audiometry, high-frequency audiometry, early auditory evoked potentials, and evoked otoacoustic emission testing were used to evaluate 30 patients (15 under amikacin and 15 under netilmicin). Ototoxicity was not significantly different in the two groups.
Collet
L
L
URA CNRS 1447 Physiologie Sensorielle, Hôpital Edouard-Herriot, Lyon, France.
Veuillet
E
E
Chanal
J M
JM
Desreux
V
V
Mermet
B
B
Disant
F
F
Morgon
A
A
D000328:Adult; D000583:Amikacin / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D001299:Audiometry / Q000379:methods*; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D009428:Netilmicin / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D012016:Reference Values
D009428:Netilmicin; D000583:Amikacin
Etude de l'ototoxicité de l'amikacine et de la nétilmicine au moyen des oto-émissions acoustiques provoquées et de l'audiométrie hautes fréquences.